Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
PLoS One ; 11(1): e0146440, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26771387

RESUMEN

Despite a plethora of literature has documented that osteoarthritis (OA) is veritably associated with oxidative stress-mediated chondrocyte death and matrix degradation, yet the possible involvement of synoviocyte abnormality as causative factor of OA has not been thoroughly investigated. For this reason, we conduct the current studies to insight into how synoviocytes could respond to an episode of folate-deprived (FD) condition. First, when HIG-82 synoviocytes were cultivated under FD condition, a time-dependent growth impediment was observed and the demise of these cells was demonstrated to be apoptotic in nature mediated through FD-evoked overproduction of reactive oxygen species (ROS) and drastically released of cytosolic calcium (Ca2+) concentrations. Next, we uncovered that FD-evoked ROS overproduction could only be strongly suppressed by either mitochondrial complex II inhibitors (TTFA and carboxin) or NADPH oxidase (NOX) inhibitors (AEBSF and apocynin), but not by mitochondrial complex I inhibitor (rotenone) and mitochondrial complex III inhibitor (antimycin A). Interestingly, this selective inhibition of FD-evoked ROS by mitochondrial complex II and NOX inhibitors was found to correlate excellently with the suppression of cytosolic Ca2+ release and reduced the magnitude of the apoptotic TUNEL-positive cells. Taken together, we present the first evidence here that FD-triggered ROS overproduction in synoviocytes is originated from mitochondrial complex II and NOX. Both elevated ROS in tandem with cytosolic Ca2+ overload serve as final arbitrators for apoptotic lethality of synoviocytes cultivated under FD condition. Thus, folate supplementation may be beneficial to patients with OA.


Asunto(s)
Calcio/metabolismo , Complejo II de Transporte de Electrones/metabolismo , Deficiencia de Ácido Fólico/metabolismo , NADPH Oxidasas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Animales , Apoptosis/efectos de los fármacos , Carboxina/farmacología , Línea Celular , Complejo II de Transporte de Electrones/antagonistas & inhibidores , Ácido Fólico/metabolismo , Células HeLa , Humanos , NADPH Oxidasas/antagonistas & inhibidores , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/fisiología , Conejos , Rotenona/farmacología , Sulfonas/farmacología , Tenoiltrifluoroacetona/farmacología
2.
C R Biol ; 338(2): 112-20, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25595298

RESUMEN

An investigation was made to manage strawberry black root rot caused by Rhizoctonia solani (R. solani) through the integration of Trichoderma harzianum (T. harzianum) isolate STA7, mustard oil cake and Provax 200. A series of preliminary experiments were conducted to select a virulent isolate of R. solani, an effective isolate of T. harzianum, a suitable organic amendment, and a suitable fungicide before setting the experiment for integration. The pathogenicity of the selected four isolates of R. solani was evaluated against strawberry and isolate SR1 was selected as the test pathogen due to its highest virulent (95.47% mortality) characteristics. Among the 20 isolates of T. harzianum, isolate STA7 showed maximum inhibition (71.97%) against the test pathogen (R. solani). Among the fungicides, Provax-200 was found to be more effective at lowest concentration (100 ppm) and highly compatible with Trichoderma isolates STA7. In the case of organic amendments, maximum inhibition (59.66%) of R. solani was obtained through mustard oil cake at the highest concentration (3%), which was significantly superior to other amendments. Minimum percentages of diseased roots were obtained with pathogen (R. solani)+Trichoderma+mustard oil cake+Provax-200 treatment, while the highest was observed with healthy seedlings with a pathogen-inoculated soil. In the case of leaf and fruit rot diseases, significantly lowest infected leaves as well as fruit rot were observed with a pathogen+Trichoderma+mustard oil cake+Provax-200 treatment in comparison with the control. A similar trend of high effectiveness was observed by the integration of Trichoderma, fungicide and organic amendments in controlling root rot and fruit diseases of strawberry. Single application of Trichoderma isolate STA7, Provax 200 or mustard oil cake did not show satisfactory performance in terms of disease-free plants, but when they were applied in combination, the number of healthy plants increased significantly. The result of the current study suggests the superiority of our integrated approach to control the sclerotia forming pathogen R. solani compared to the individual treatment either by an antagonist or by a fungicide or by mustard oil cake.


Asunto(s)
Basidiomycota/efectos de los fármacos , Fragaria/microbiología , Fungicidas Industriales/farmacología , Enfermedades de las Plantas/prevención & control , Aceites de Plantas/farmacología , Rhizoctonia/efectos de los fármacos , Trichoderma/fisiología , Alanina/análogos & derivados , Alanina/farmacología , Basidiomycota/crecimiento & desarrollo , Basidiomycota/aislamiento & purificación , Basidiomycota/patogenicidad , Bencimidazoles/farmacología , Carbamatos/farmacología , Carboxina/farmacología , Evaluación Preclínica de Medicamentos , Sinergismo Farmacológico , Frutas/microbiología , Planta de la Mostaza , Control Biológico de Vectores , Enfermedades de las Plantas/microbiología , Hojas de la Planta/microbiología , Raíces de Plantas/microbiología , Rhizoctonia/crecimiento & desarrollo , Rhizoctonia/aislamiento & purificación , Rhizoctonia/patogenicidad , Microbiología del Suelo , Virulencia
3.
Pak J Biol Sci ; 17(4): 511-6, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25911838

RESUMEN

Field experiments were conducted during 2010-11 and 2011-12 to assess the yield losses due to Alternaria blight disease caused by Alternaria lini and A. linicola in recently released cultivars and their management with the integration of Trichoderma viride, fungicides and plant extract. Disease severity on leaves varied from 41.07% (Parvati) to 65.01% (Chambal) while bud damage per cent ranged between 23.56% (Shekhar) to 46.12% (T-397), respectively in different cultivars. Maximum yield loss of 58.44% was recorded in cultivar Neelum followed by Parvati (55.56%), Meera (55.56%) and Chambal (51.72%), respectively while minimum loss was recorded in Kiran (19.99%) and Jeevan (22.22%). Minimum mean disease severity (19.47%) with maximum disease control (69.74%) was recorded with the treatment: seed treatment (ST) with vitavax power (2 g kg(-1) seed) + 2 foliar sprays (FS) of Saaf (a mixture of carbendazim+mancozeb) 0.2% followed by ST with Trichoderma viride (4g kg(-1) seed) + 2 FS of Saaf (0.2%). Minimum bud damage (13.75%) with maximum control (60.94%) was recorded with treatment of ST with vitavax power+2 FS of propiconazole (0.2%). Maximum mean seed yield (1440 kg ha(-1)) with maximum net return (Rs. 15352/ha) and benefit cost ratio (1:11.04) was obtained with treatment ST with vitavax power + 2 FS of Neem leaf extract followed by treatment ST with vitavax power+2 FS of Saaf (1378 kg ha(-1)).


Asunto(s)
Alternaria/efectos de los fármacos , Alternariosis/prevención & control , Azadirachta , Lino/microbiología , Fungicidas Industriales/farmacología , Control Biológico de Vectores , Control de Plagas/métodos , Enfermedades de las Plantas/prevención & control , Trichoderma/fisiología , Aerosoles , Alternaria/patogenicidad , Alternariosis/microbiología , Azadirachta/química , Bencimidazoles/farmacología , Carbamatos/farmacología , Carboxina/farmacología , Lino/crecimiento & desarrollo , Maneb/farmacología , Enfermedades de las Plantas/microbiología , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta/crecimiento & desarrollo , Hojas de la Planta/microbiología , Polvos , Triazoles/farmacología , Zineb/farmacología
4.
Proc Natl Acad Sci U S A ; 88(15): 6740-4, 1991 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-1713689

RESUMEN

Oxathiin carboxanilide (OC), NSC 615985, a compound originally synthesized as a potential fungicide, was demonstrated to be highly active in preventing human immunodeficiency virus (HIV)-induced cell killing and in inhibiting HIV reproduction. Virus-infected CD4+ lymphocytes were completely protected by 0.5 microM OC, whereas no toxicity was observed at concentrations below 50 microM OC. Production of infectious virus, viral p24 antigen, and virion reverse transcriptase were reduced by OC at concentrations that prevented viral cell killing. A variety of CD4+ T-cell lines were protected by OC from HIV cytopathicity, and OC inhibited two distinct strains of HIV-1. However, HIV-2 infections were unaffected by OC. OC had no direct effect on virions of HIV or on the enzymatic activities of HIV reverse transcriptase or HIV protease. Time-limited treatments of cells with OC before, during, or after exposure of cells to virus failed to protect cells from the eventual cytopathic effects of HIV, and OC failed to inhibit the production of virus from cells in which infection was established or from chronically infected cells. We conclude that the highly active OC has a reversible effect on some early stage of HIV-1 reproduction and cytopathicity. Pilot in vivo experiments showed that circulating concentrations of OC exceeding 1 microM could be achieved and sustained in hamsters for at least a week with no remarkable toxicological sequelae. OC represents a new class of anti-HIV agents that are promising candidates for drug development.


Asunto(s)
Antivirales/farmacología , Carboxina/análogos & derivados , VIH-1/fisiología , Replicación Viral/efectos de los fármacos , Animales , Antígenos CD4/análisis , Carboxina/sangre , Carboxina/farmacología , Carboxina/toxicidad , Línea Celular , Cricetinae , Evaluación Preclínica de Medicamentos , Inhibidores de la Proteasa del VIH , VIH-1/efectos de los fármacos , VIH-1/enzimología , Humanos , Inhibidores de la Transcriptasa Inversa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA